WP-UserOnline Plugin up to 2.87.6 on WordPress templates[browsingpage][text] cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.2 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, was found in WP-UserOnline Plugin up to 2.87.6 on WordPress. Affected by this vulnerability is an unknown functionality. Such manipulation of the argument templates[browsingpage][text] leads to cross site scripting. This vulnerability is traded as CVE-2022-2473. The attack may be launched remotely. There is no exploit available.
Details
A vulnerability was found in WP-UserOnline Plugin up to 2.87.6 on WordPress (WordPress Plugin). It has been rated as problematic. Affected by this issue is some unknown functionality. The manipulation of the argument templates[browsingpage][text] with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. CVE summarizes:
The WP-UserOnline plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the ‘templates[browsingpage][text]' parameter in versions up to, and including, 2.87.6 due to insufficient input sanitization and output escaping. This makes it possible for authenticated attackers with administrative capabilities and above to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page. The only affects multi-site installations and installations where unfiltered_html is disabled.
The weakness was shared 09/07/2022. The advisory is shared for download at wordfence.com. This vulnerability is handled as CVE-2022-2473 since 07/19/2022. Successful exploitation requires user interaction by the victim. There are known technical details, but no exploit is available. The MITRE ATT&CK project declares the attack technique as T1059.007.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.2VulDB Meta Temp Score: 4.2
VulDB Base Score: 2.4
VulDB Temp Score: 2.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 4.8
NVD Vector: 🔍
CNA Base Score: 5.5
CNA Vector (Wordfence): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
07/19/2022 🔍09/07/2022 🔍
09/07/2022 🔍
04/08/2026 🔍
Sources
Advisory: 167864Status: Not defined
CVE: CVE-2022-2473 (🔍)
GCVE (CVE): GCVE-0-2022-2473
GCVE (VulDB): GCVE-100-207944
Entry
Created: 09/07/2022 09:39Updated: 04/08/2026 23:05
Changes: 09/07/2022 09:39 (49), 10/13/2022 14:14 (1), 10/13/2022 14:15 (11), 04/08/2026 23:05 (16)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.